Patient groups push back against Gilead’s pricey HIV prevention treatment
LOS ANGELES (Reuters) – Gilead Sciences Inc (GILD.O) hopes to soon introduce a pricey new pill to prevent HIV in people at risk of contracting the infection, but the drugmaker…